Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.

Vitale SR, Sieuwerts AM, Beije N, Kraan J, Angus L, Mostert B, Reijm EA, Van NM, van Marion R, Dirix LY, Hamberg P, de Jongh FE, Jager A, Foekens JA, Vigneri P, Sleijfer S, Jansen MPHM, Martens JWM.

J Mol Diagn. 2018 Oct 6. pii: S1525-1578(18)30238-1. doi: 10.1016/j.jmoldx.2018.08.010. [Epub ahead of print]

PMID:
30296589
2.

Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing.

Doebar SC, Krol NM, van Marion R, Brouwer RWW, van Ijcken WFJ, Martens JM, Dinjens WNM, van Deurzen CHM.

Virchows Arch. 2018 Oct 4. doi: 10.1007/s00428-018-2463-5. [Epub ahead of print]

PMID:
30284611
3.

Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.

Smit KN, van Poppelen NM, Vaarwater J, Verdijk R, van Marion R, Kalirai H, Coupland SE, Thornton S, Farquhar N, Dubbink HJ, Paridaens D, de Klein A, Kiliç E.

Mod Pathol. 2018 May;31(5):763-771. doi: 10.1038/modpathol.2017.187. Epub 2018 Jan 12.

PMID:
29327717
4.

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett's esophagus and esophageal adenocarcinoma.

van Nistelrooij AMJ, van Marion R, van Ijcken WFJ, de Klein A, Wagner A, Biermann K, Spaander MCW, van Lanschot JJB, Dinjens WNM, Wijnhoven BPL.

Fam Cancer. 2018 Jul;17(3):435-440. doi: 10.1007/s10689-017-0054-2.

5.

Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA.

Weerts MJA, van Marion R, Helmijr JCA, Beaufort CM, Krol NMG, Trapman-Jansen AMAC, Dinjens WNM, Sleijfer S, Jansen MPHM, Martens JWM.

Sci Rep. 2017 May 18;7(1):2136. doi: 10.1038/s41598-017-02388-7.

6.

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.

van Nistelrooij AM, van Marion R, Koppert LB, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Wijnhoven BP, Dinjens WN.

BMC Res Notes. 2017 Apr 4;10(1):144. doi: 10.1186/s13104-017-2456-5.

7.

Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm B, Benstead K, Dinjens WN, van Marion R, van Diest PJ, Martens JW, van Deurzen CH.

Mod Pathol. 2017 Apr;30(4):509-518. doi: 10.1038/modpathol.2016.229. Epub 2017 Jan 13.

8.

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.

Li Y, Buijs-Gladdines JG, Canté-Barrett K, Stubbs AP, Vroegindeweij EM, Smits WK, van Marion R, Dinjens WN, Horstmann M, Kuiper RP, Buijsman RC, Zaman GJ, van der Spek PJ, Pieters R, Meijerink JP.

PLoS Med. 2016 Dec 20;13(12):e1002200. doi: 10.1371/journal.pmed.1002200. eCollection 2016 Dec.

9.

Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.

Papathomas TG, Duregon E, Korpershoek E, Restuccia DF, van Marion R, Cappellesso R, Sturm N, Rossi G, Coli A, Zucchini N, Stoop H, Oosterhuis W, Ventura L, Volante M, Fassina A, Dinjens WN, Papotti M, de Krijger RR.

Hum Pathol. 2016 Dec;58:113-122. doi: 10.1016/j.humpath.2016.08.006. Epub 2016 Aug 31.

PMID:
27589897
10.

Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of Gliomas.

Dubbink HJ, Atmodimedjo PN, van Marion R, Krol NMG, Riegman PHJ, Kros JM, van den Bent MJ, Dinjens WNM.

J Mol Diagn. 2016 Sep;18(5):775-786. doi: 10.1016/j.jmoldx.2016.06.002. Epub 2016 Jul 25. Erratum in: J Mol Diagn. 2016 Nov;18(6):933.

PMID:
27461031
11.

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen.

Jansen MP, Martens JW, Helmijr JC, Beaufort CM, van Marion R, Krol NM, Monkhorst K, Trapman-Jansen AM, Meijer-van Gelder ME, Weerts MJ, Ramirez-Ardila DE, Dubbink HJ, Foekens JA, Sleijfer S, Berns EM.

Oncotarget. 2016 Jul 12;7(28):43412-43418. doi: 10.18632/oncotarget.9727.

12.

Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.

Yavuzyigitoglu S, Mensink HW, Smit KN, Vaarwater J, Verdijk RM, Beverloo B, Brüggenwirth HT, van Marion R, Dubbink HJ, Paridaens D, Naus NC, de Klein A, Kiliç E; Rotterdam Ocular Melanoma Study Group (ROMS).

Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2232-9. doi: 10.1167/iovs.15-18608.

PMID:
27116551
13.

Early onset esophageal adenocarcinoma: a distinct molecular entity?

van Nistelrooij AM, van Marion R; PALGA-group, Biermann K, Spaander MC, van Lanschot JJ, Wijnhoven BP, Dinjens WN.

Oncoscience. 2016 Feb 1;3(1):42-8. eCollection 2016.

14.

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma.

van Nistelrooij AM, van der Korput HA, Broer L, van Marion R, van Berge Henegouwen MI, van Noesel CJ, Biermann K, Spaander MC, Tilanus HW, van Lanschot JJ, Hofman A, Uitterlinden AG, Wijnhoven BP, Dinjens WN.

J Carcinog. 2015 May 21;14:5. doi: 10.4103/1477-3163.157441. eCollection 2015.

15.

Absence of TERT promoter mutations in esophageal adenocarcinoma.

van Nistelrooij AM, Zwarthoff EC, Post E, Lurkin I, van Marion R, Korpershoek E, Biermann K, Wijnhoven BP, Dinjens WN.

Int J Cancer. 2014 Apr 15;134(8):2014-5. No abstract available. Erratum in: Int J Cancer. 2014 Nov 1;135(9):E8. Kopershoek, E [corrected to Korpershoek, E].

16.

Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.

Boonstra JJ, van Marion R, Douben HJ, Lanchbury JS, Timms KM, Abkevich V, Tilanus HW, de Klein A, Dinjens WN.

Genes Chromosomes Cancer. 2012 Mar;51(3):272-82. doi: 10.1002/gcc.20952. Epub 2011 Nov 12.

PMID:
22081516
17.

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response.

Taal W, Dubbink HJ, Zonnenberg CB, Zonnenberg BA, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Kros JM, Kouwenhoven MC, van Marion R, van Heuvel I, van der Holt B, Bromberg JE, Sillevis Smitt PA, Dinjens WN, van den Bent MJ; Dutch Society for Neuro-Oncology.

Neuro Oncol. 2011 Feb;13(2):235-41. doi: 10.1093/neuonc/noq177. Epub 2010 Dec 21.

18.

Functional polymorphisms associated with disease-free survival in resected carcinoma of the esophagus.

Boonstra JJ, van Marion R, Tilanus HW, Dinjens WN.

J Gastrointest Surg. 2011 Jan;15(1):48-56. doi: 10.1007/s11605-010-1358-9. Epub 2010 Oct 5.

19.

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

van den Bent MJ, Dubbink HJ, Marie Y, Brandes AA, Taphoorn MJ, Wesseling P, Frenay M, Tijssen CC, Lacombe D, Idbaih A, van Marion R, Kros JM, Dinjens WN, Gorlia T, Sanson M.

Clin Cancer Res. 2010 Mar 1;16(5):1597-604. doi: 10.1158/1078-0432.CCR-09-2902. Epub 2010 Feb 16.

20.

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma.

Gravendeel LA, Kloosterhof NK, Bralten LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC, Michiels E, Kros JM, van den Bent M, Smitt PA, French PJ.

Hum Mutat. 2010 Mar;31(3):E1186-99. doi: 10.1002/humu.21201.

PMID:
20077503
21.

Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.

Boonstra JJ, van Marion R, Beer DG, Lin L, Chaves P, Ribeiro C, Pereira AD, Roque L, Darnton SJ, Altorki NK, Schrump DS, Klimstra DS, Tang LH, Eshleman JR, Alvarez H, Shimada Y, van Dekken H, Tilanus HW, Dinjens WN.

J Natl Cancer Inst. 2010 Feb 24;102(4):271-4. doi: 10.1093/jnci/djp499. Epub 2010 Jan 14.

22.

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide.

Dubbink HJ, Taal W, van Marion R, Kros JM, van Heuvel I, Bromberg JE, Zonnenberg BA, Zonnenberg CB, Postma TJ, Gijtenbeek JM, Boogerd W, Groenendijk FH, Smitt PA, Dinjens WN, van den Bent MJ.

Neurology. 2009 Nov 24;73(21):1792-5. doi: 10.1212/WNL.0b013e3181c34ace.

PMID:
19933982
23.

The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction.

Grotenhuis BA, Wijnhoven BP, van Marion R, van Dekken H, Hop WC, Tilanus HW, van Lanschot JJ, van Eijck CH.

J Thorac Cardiovasc Surg. 2009 Sep;138(3):608-12. doi: 10.1016/j.jtcvs.2008.11.061. Epub 2009 Feb 23.

24.

Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.

van Dekken H, Tilanus HW, Hop WC, Dinjens WN, Wink JC, Vissers KJ, van Marion R.

Cancer Genet Cytogenet. 2009 Feb;189(1):37-42. doi: 10.1016/j.cancergencyto.2008.08.018.

PMID:
19167610
25.

Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer.

Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, Boormans JL, van der Kwast TH, van Dekken H, Bangma CH, Korsten H, Kraaij R, Jenster G, Trapman J.

Cancer Res. 2008 Sep 15;68(18):7541-9. doi: 10.1158/0008-5472.CAN-07-5930.

26.

Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels.

van Dekken H, van Marion R, Vissers KJ, Hop WC, Dinjens WN, Tilanus HW, Wink JC, van Duin M.

Genes Chromosomes Cancer. 2008 Aug;47(8):649-56. doi: 10.1002/gcc.20570.

PMID:
18438866
27.

Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristics.

Verhoef C, van Dekken H, Hofland LJ, Zondervan PE, de Wilt JH, van Marion R, de Man RA, IJzermans JN, van Eijck CH.

Dig Surg. 2008;25(1):21-6. doi: 10.1159/000117819. Epub 2008 Feb 21.

PMID:
18292657
28.

High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.

van Duin M, van Marion R, Vissers KJ, Hop WC, Dinjens WN, Tilanus HW, Siersema PD, van Dekken H.

Cytogenet Genome Res. 2007;118(2-4):130-7.

PMID:
18000363
29.

Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.

Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, Nishihira T, Tselepis C, Hainaut P, Lowe AW, Beverloo BH, van Dekken H, Tilanus HW, Dinjens WN.

Cancer Res. 2007 Sep 1;67(17):7996-8001.

30.

Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R.

Smeenk HG, Erdmann J, van Dekken H, van Marion R, Hop WC, Jeekel J, van Eijck CH.

Dig Surg. 2007;24(1):38-45. Epub 2007 Mar 16.

31.

Chromosomal and microsatellite instability of adenocarcinomas and dysplastic lesions (DALM) in ulcerative colitis.

van Dieren JM, Wink JC, Vissers KJ, van Marion R, Hoogmans MM, Dinjens WN, Schouten WR, Tanke HJ, Szuhai K, Kuipers EJ, van der Woude CJ, van Dekken H.

Diagn Mol Pathol. 2006 Dec;15(4):216-22.

PMID:
17122649
32.
33.

Genomic analysis of a case of multifocal adenocarcinoma in ulcerative colitis.

van Dekken H, Wink JC, Vissers KJ, van Marion R, Franken PF, Hoogmans MM, Dinjens WN, Schouten WR, Kuipers EJ, van der Woude CJ.

Virchows Arch. 2006 Dec;449(6):716-21. Epub 2006 Nov 8.

PMID:
17091253
34.

Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.

Postma R, van Marion R, van Duin M, Vissers KJ, Wink JC, Schröder FH, Tanke HJ, Szuhai K, van der Kwast TH, van Dekken H.

Anticancer Res. 2006 Mar-Apr;26(2A):1193-200.

35.

Genomic analysis of early adenocarcinoma of the esophagus or gastroesophageal junction: tumor progression is associated with alteration of 1q and 8p sequences.

van Dekken H, Wink JC, Vissers KJ, van Marion R, Koppert LB, Tilanus HW, Siersema PD, Tanke HJ, Szuhai K, Hop WC.

Genes Chromosomes Cancer. 2006 May;45(5):516-25.

PMID:
16479570
36.

High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.

van Duin M, van Marion R, Vissers K, Watson JE, van Weerden WM, Schröder FH, Hop WC, van der Kwast TH, Collins C, van Dekken H.

Genes Chromosomes Cancer. 2005 Dec;44(4):438-49.

PMID:
16130124
37.

Cell biological evaluation of liver cell carcinoma, dysplasia and adenoma by tissue micro-array analysis.

van Dekken H, Verhoef C, Wink J, van Marion R, Vissers KJ, Hop WC, de Man RA, IJzermans JN, van Eijck CH, Zondervan PE.

Acta Histochem. 2005;107(3):161-71.

PMID:
16000213
38.

Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.

van Duin M, van Marion R, Watson JE, Paris PL, Lapuk A, Brown N, Oseroff VV, Albertson DG, Pinkel D, de Jong P, Nacheva EP, Dinjens W, van Dekken H, Collins C.

Cytometry A. 2005;63(1):10-9.

Supplemental Content

Loading ...
Support Center